High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$461K
$461,354
Total Sells (Filtered)
$2.7M
$2,728,041
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
OCUL
S
OCULAR THERAPEUTIX, INC
Dugel Pravin
• Officer • See Remarks
Sell to Cover
2026-02-23
$166,064
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • See Remarks
Sell to Cover
|
2026-02-23 | $166,064 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Heier Jeffrey S.
• Officer • Chief Scientific Officer
Sell to Cover
2026-02-23
$25,312
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-02-23 | $25,312 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Kaiser Peter
• Officer • Chief Development Officer
Sell to Cover
2026-02-23
$23,267
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Development Officer
Sell to Cover
|
2026-02-23 | $23,267 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Nayak Sanjay
• Officer • Chief Strategy Officer
Sell to Cover
2026-02-23
$14,565
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Strategy Officer
Sell to Cover
|
2026-02-23 | $14,565 | S | Form 4 |
|
OCUL
P
OCULAR THERAPEUTIX, INC
LINDSTROM RICHARD L MD
• Director
Discretionary BuyΔOwn +32.3%
2026-02-20
$461,354
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Director
Discretionary BuyΔOwn +32.3%
|
2026-02-20 | $461,354 | P | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Waheed Nadia
• Officer • Chief Medical Officer
Sell to Cover
2026-02-20
$27,167
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-20 | $27,167 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Dugel Pravin
• Officer • See Remarks
Sell to Cover
2026-02-12
$1,128,933Large
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • See Remarks
Sell to Cover
|
2026-02-12 | $1,128,933Large | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Nayak Sanjay
• Officer • Chief Strategy Officer
Sell to Cover
2026-02-12
$93,546
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Strategy Officer
Sell to Cover
|
2026-02-12 | $93,546 | S | Form 4 |
| OCUL |
OCULAR THERAPEUTIX, INC
|
COO
Sell to Cover
|
2026-02-12 | $103,472 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Waheed Nadia
• Officer • Chief Medical Officer
Sell to Cover
2026-02-12
$71,082
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-02-12 | $71,082 | S | Form 4 |
| OCUL |
OCULAR THERAPEUTIX, INC
|
COO
Sell to Cover
|
2026-02-04 | $51,539 | S | Form 4 |
| OCUL |
OCULAR THERAPEUTIX, INC
|
COO
Sell to Cover
|
2026-02-02 | $49,859 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Dugel Pravin
• Officer • See Remarks
Sell to Cover
2025-11-24
$235,141
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • See Remarks
Sell to Cover
|
2025-11-24 | $235,141 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Heier Jeffrey S.
• Officer • Chief Scientific Officer
Sell to Cover
2025-11-24
$41,767
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Scientific Officer
Sell to Cover
|
2025-11-24 | $41,767 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Kaiser Peter
• Officer • Chief Development Officer
Sell to Cover
2025-11-24
$36,144
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Development Officer
Sell to Cover
|
2025-11-24 | $36,144 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Nayak Sanjay
• Officer • Chief Strategy Officer
Sell to Cover
2025-11-24
$22,611
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Strategy Officer
Sell to Cover
|
2025-11-24 | $22,611 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Saroj Namrata
• Officer • Chief Business Officer
Sell to CoverΔOwn -12.9%
2025-11-05
$277,790
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Business Officer
Sell to CoverΔOwn -12.9%
|
2025-11-05 | $277,790 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Anderman Todd
• Officer • Chief Legal Officer
Sell to CoverΔOwn -11.3%
2025-10-08
$137,369
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Legal Officer
Sell to CoverΔOwn -11.3%
|
2025-10-08 | $137,369 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Heier Jeffrey S.
• Officer • Chief Scientific Officer
Sell to Cover
2025-10-02
$115,942
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Scientific Officer
Sell to Cover
|
2025-10-02 | $115,942 | S | Form 4 |
|
OCUL
S
OCULAR THERAPEUTIX, INC
Kaiser Peter
• Officer • Chief Development Officer
Sell to Cover
2025-10-02
$106,473
|
||||||
| OCUL |
OCULAR THERAPEUTIX, INC
|
Officer • Chief Development Officer
Sell to Cover
|
2025-10-02 | $106,473 | S | Form 4 |